Best Quarter in NCZ History, page-74

We are still operating in a highly favourable macro environment for this stock. Zinc price, treatment costs, cashflow generation should be favourable.

At the last call the ceo mentioned Aug fcf around $12m and that he would provide an update on the Jameson Cell in a week which is now overdue So hoping tomorrow is the day.

I’m content with if they achieve recovery over 50% and their ability to self fund the expansions.